NFKB1 and inflammatory bowel disease: Aberrant NF-κB activation has been observed in intestinal mucosal biopsies from inflammatory bowel disease (IBD) patients with active Crohn’s disease or ulcerative colitis, promoting the production of pro-inflammatory mediators [9,10].